Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06037187 · ClinicalTrials.gov registry record
Coagulopathy of Immunodermatologic Diseases
A clinical trial of Autoimmune Bullous Dermatosis, sponsored by University of Nebraska.
- Recruiting
- Registry status
- 39
- Enrollment target
- 1
- Study location
NCT06037187 is a study of Autoimmune Bullous Dermatosis that is actively recruiting participants, run by University of Nebraska. The registered enrollment target is 39 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06037187, a study of Autoimmune Bullous Dermatosis, is actively recruiting participants, sponsored by University of Nebraska.
- RECRUITING
- Registry status
- 39 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will examine the coagulation and fibrinolysis profiles of those with autoimmune skin diseases. Blood samples will be collected from participants with active/poorly controlled immune-mediated skin diseases and mild/latent/well-controlled immune-mediated skin diseases. A one-time sample from 15 general dermatology outpatients who do not have a known or suspected diagnosis of bullous diseases, immune-mediated dermatologic condition, or cutaneous malignancy will also be collected to serve as control. Blood samples from both participant populations will be analyzed for coagulation and inflammatory markers and compared. The results of this study may help inform future studies on the utility of analyzing coagulation and fibrinolysis profiles of patients with autoimmune skin diseases.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Blood Draw
Study Locations (1)
Nebraska
- University of Nebraska Medical Center - Omaha
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 39 participants |
| Start Date | 2023-05-09 |
| Est. Completion | 2025-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06037187
The ClinicalTrials.gov registry entry for NCT06037187 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 39 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Nebraska, which has 407 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Autoimmune Bullous Dermatosis appearing as the primary indexed condition, and to 1 intervention - of which Blood Draw is the first listed.
NCT06037187 reports 1 study location spanning 1 distinct geographic area - top geographies include Nebraska.
Frequently Asked Questions
What is clinical trial NCT06037187 about?
NCT06037187 is a clinical study titled "Coagulopathy of Immunodermatologic Diseases". This study will examine the coagulation and fibrinolysis profiles of those with autoimmune skin diseases. Blood samples will be collected from participants with active/poorly controlled immune-mediated skin diseases and mild/latent/well-controlled immune-mediated skin diseases. A one-time sample fro...
What is the current status of trial NCT06037187?
This trial is currently recruiting. The enrollment target is 39 participants. The study started on 2023-05-09. Estimated completion is 2025-12.
What conditions does trial NCT06037187 study?
This clinical trial studies the following conditions: Autoimmune Bullous Dermatosis.
What interventions are being tested in trial NCT06037187?
The interventions under investigation include: Blood Draw (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT06037187?
This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06037187 being conducted?
This trial has 1 study location across Nebraska. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.